company background image
ICR

Intelicare HoldingsASX:ICR Stock Report

Market Cap

AU$8.2m

7D

8.2%

1Y

-64.4%

Updated

22 Oct, 2021

Data

Company Financials
ICR fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

ICR Overview

Intelicare Holdings Limited engages in the sale of a predictive analytics hardware and software package for use in the aged care and health industries in Australia.

Intelicare Holdings Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Intelicare Holdings
Historical stock prices
Current Share PriceAU$0.10
52 Week HighAU$0.094
52 Week LowAU$0.33
Beta0
1 Month Change10.53%
3 Month Change-41.67%
1 Year Change-64.41%
3 Year Changen/a
5 Year Changen/a
Change since IPO-66.67%

Recent News & Updates

Shareholder Returns

ICRAU Healthcare ServicesAU Market
7D8.2%0.2%0.7%
1Y-64.4%41.1%21.4%

Return vs Industry: ICR underperformed the Australian Healthcare Services industry which returned 41.1% over the past year.

Return vs Market: ICR underperformed the Australian Market which returned 21.4% over the past year.

Price Volatility

Is ICR's price volatile compared to industry and market?
ICR volatility
ICR Beta0
Industry Beta0.49
Market Beta1

Stable Share Price: ICR is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: ICR's weekly volatility (10%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2016n/aJason Wallerhttps://intelicare.com.au

Intelicare Holdings Limited engages in the sale of a predictive analytics hardware and software package for use in the aged care and health industries in Australia. It offers InteliCare, a monitoring system; and InteliLiving for seniors and people with disability. The company was founded in 2016 and is headquartered in Leederville, Australia.

Intelicare Holdings Fundamentals Summary

How do Intelicare Holdings's earnings and revenue compare to its market cap?
ICR fundamental statistics
Market CapAU$8.16m
Earnings (TTM)-AU$4.36m
Revenue (TTM)AU$372.22k

23.8x

P/S Ratio

-2.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ICR income statement (TTM)
RevenueAU$372.22k
Cost of RevenueAU$1.89m
Gross Profit-AU$1.51m
ExpensesAU$2.85m
Earnings-AU$4.36m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.052
Gross Margin-406.81%
Net Profit Margin-1,171.59%
Debt/Equity Ratio0%

How did ICR perform over the long term?

See historical performance and comparison

Valuation

Is Intelicare Holdings undervalued compared to its fair value and its price relative to the market?

3.41x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate ICR's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate ICR's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: ICR is unprofitable, so we can't compare its PE Ratio to the Global Healthcare Services industry average.

PE vs Market: ICR is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate ICR's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: ICR is good value based on its PB Ratio (3.4x) compared to the AU Healthcare Services industry average (4.1x).


Future Growth

How is Intelicare Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

40.8%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Intelicare Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Intelicare Holdings performed over the past 5 years?

-70.7%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: ICR is currently unprofitable.

Growing Profit Margin: ICR is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if ICR's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare ICR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ICR is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (39.5%).


Return on Equity

High ROE: ICR has a negative Return on Equity (-168.48%), as it is currently unprofitable.


Financial Health

How is Intelicare Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: ICR's short term assets (A$3.2M) exceed its short term liabilities (A$827.9K).

Long Term Liabilities: ICR's short term assets (A$3.2M) exceed its long term liabilities (A$14.7K).


Debt to Equity History and Analysis

Debt Level: ICR is debt free.

Reducing Debt: ICR had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ICR has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: ICR has less than a year of cash runway if free cash flow continues to reduce at historical rates of 62.2% each year


Dividend

What is Intelicare Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate ICR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ICR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ICR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ICR's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ICR's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.0yrs

Average board tenure


CEO

Jason Waller

2yrs

Tenure

AU$461,364

Compensation

Mr. Jason Waller, CSC, MMgt, BSc, GAICD, has been the Chief Executive Officer, Managing Director and a Director of Intelicare Holdings Limited since October 23, 2019. Mr. Waller served as the Chief Executi...


CEO Compensation Analysis

Compensation vs Market: Jason's total compensation ($USD345.51K) is about average for companies of similar size in the Australian market ($USD303.33K).

Compensation vs Earnings: Jason's compensation has been consistent with company performance over the past year.


Board Members

Experienced Board: ICR's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.5%.


Top Shareholders

Company Information

Intelicare Holdings Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Intelicare Holdings Limited
  • Ticker: ICR
  • Exchange: ASX
  • Founded: 2016
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: AU$8.164m
  • Shares outstanding: 84.17m
  • Website: https://intelicare.com.au

Location

  • Intelicare Holdings Limited
  • 299 Vincent Street
  • Level 1
  • Leederville
  • Western Australia
  • 6007
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/22 07:05
End of Day Share Price2021/10/22 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.